IGC Pharma, Inc. Quarterly Share-based Payment Arrangement, Expense in USD from Q2 2018 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
IGC Pharma, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q2 2018 to Q2 2024.
  • IGC Pharma, Inc. Share-based Payment Arrangement, Expense for the quarter ending June 30, 2024 was $402K, a 12.6% increase year-over-year.
  • IGC Pharma, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $1.77M, a 37.6% decline from 2022.
  • IGC Pharma, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $2.84M, a 29.4% increase from 2021.
  • IGC Pharma, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $2.2M, a 234% increase from 2020.
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $402K +$45K +12.6% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-07
Q2 2023 $357K -$795K -69% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-07
Q2 2022 $1.15M +$1.03M +822% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q2 2021 $125K -$41K -24.7% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-05
Q2 2020 $166K -$42K -20.2% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-11
Q2 2019 $208K +$46K +28.4% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-19
Q4 2018 $13K Oct 1, 2018 Dec 31, 2018 10-Q 2020-02-10
Q2 2018 $162K Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.